Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

231.52
-0.8300-0.36%
Post-market: 231.550.0300+0.01%18:28 EDT
Volume:1.00M
Turnover:233.31M
Market Cap:15.03B
PE:15.83
High:236.00
Open:231.60
Low:230.39
Close:232.35
52wk High:266.38
52wk Low:128.80
Shares:64.91M
Float Shares:62.69M
Volume Ratio:1.24
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.13
PE(LYR):-39.64

Loading ...

Jazz Pharmaceuticals Initiated at Buy by Citigroup

Dow Jones
·
Yesterday

Jazz Pharmaceuticals Plc : Citigroup Initiates Coverage with Buy Rating; Target Price $325

THOMSON REUTERS
·
Yesterday

Citigroup Initiates Jazz Pharmaceuticals at Buy With $325 Price Target

MT Newswires Live
·
Yesterday

US Research Roundup-Alnylam Pharmaceuticals, Carvana, MongoDB

Reuters
·
Yesterday

Bernstein Reaffirms Their Hold Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
Sep 26

Goldman Sachs Resumes Coverage with a Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
Sep 24

Jazz Reprices USD 1.9 Billion Term Loan, Extends Maturity to 2033

Reuters
·
Sep 24

Jazz Pharmaceuticals - Unit Enters Amendment No. 4 to Credit Agreement on Sept 23, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 24

Jazz Pharmaceuticals - Unit Borrows $273.31 Mln in Additional Tranche B-3 Dollar Term Loans - SEC Filing

THOMSON REUTERS
·
Sep 24

Nvidia, QIA-Backed Iambic Therapeutics Files for US IPO as Biotech Boom Rolls On

Reuters
·
Sep 22

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

THOMSON REUTERS
·
Sep 15

Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says

MT Newswires Live
·
Sep 12

Jazz Pharmaceuticals Price Target Raised to $337.00/Share from $315.00 by UBS

Dow Jones
·
Sep 11

UBS Adjusts Jazz Pharmaceuticals PT to $337 From $315, Maintains Buy Rating

MT Newswires Live
·
Sep 11

Jazz Pharmaceuticals Plc : UBS Raises Target Price to $337 from $315

THOMSON REUTERS
·
Sep 11

Jazz Pharma CEO Renee D. Gala Disposes of Ordinary Shares Worth $970,664.07

Reuters
·
Sep 11

Jazz Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Sep 10

Jazz Pharmaceuticals Plc : Barclays Raises Target Price to $271 from $270

THOMSON REUTERS
·
Sep 10

Jazz Pharma Director Bruce C. Cozadd Disposes of USD 1.79 Million in Ordinary Shares

Reuters
·
Sep 03

Jazz Pharma Management Joins Wells Fargo Healthcare Conference Fireside Chat

Reuters
·
Sep 03